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AbstrAct | Chronic obstructive pulmonary disease 
(COPD) is related to a low body mass index (BMI), reduced 
functional capacity and reduced bone density, thus justify-
ing the importance of evaluating all of these parameters in 
the patients with the disease. This is a cross-sectional study, 
with sample consisting of 20 patients who performed mea-
surement of body composition by bioelectrical impedance, 
evaluation of functional capacity by the distance traveled in 
the Incremental Shuttle Walk Test (ISWT) and assessment of 
severity of obstruction by spirometry. Significant differences 
were found between the travelled and scheduled distance 
in the ISWT (p<0.01), positive correlations between muscle 
mass and distance walked in ISWT (r=0.54 with p=0.01), with 
FEV
1
 (r=0.488 with p=0.02), FEV
1
 and bone mass (r=0.497 
with p=0.02) and distance traveled with FEV
1
 (r=0,541 with 
p=0.01). The correlations found in this study, besides con-
firming the hypothesis that the severity of the obstruction 
presented by the change in the lung parenchyma in pa-
tients with COPD is related to changes in body composition 
and functional capacity reduction, also highlight the correla-
tion with bone mass.
Keywords  |  Body Mass Index; Pulmonary Disease, 
Chronic Obstructive/physiopathology; Exercise Tolerance.
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resumo  |  A doença pulmonar obstrutiva crônica (DPOC) 
está relacionada a um baixo índice de massa corporal (IMC), 
à redução da capacidade funcional e à redução da densidade 
óssea, justificando assim a importância de se avaliar todos es-
ses parâmetros nos pacientes portadores da doença. Trata-se 
de um estudo transversal, com amostra composta por 20 
pacientes, que realizaram medida de composição corporal 
por bioimpedância, avaliação da capacidade funcional pela 
distância percorrida no Incremental Shuttle Walk Test (ISWT) e 
avaliação da gravidade da obstrução pela espirometria. Foram 
encontradas diferenças significantes entre a distância percor-
rida e prevista do ISWT (p<0,01), correlações positivas entre 
massa muscular e distância percorrida no ISWT (r=0,54 com 
p=0,01), com VEF
1
 (r=0,488 com p=0,02), VEF
1
 e massa óssea 
(r=0,497 com p=0,02) e distância percorrida com VEF
1
 (r=0,541 
com p=0,01). As correlações encontradas neste estudo, além 
de confirmarem a hipótese de que a gravidade da obstrução 
apresentada pela alteração no parênquima pulmonar nos 
pacientes com DPOC está relacionada com as alterações na 
composição corporal e com a redução da capacidade funcio-
nal, evidenciam também a correlação com a massa óssea.
Descritores  | Índice de Massa Corporal; Doença Pulmonar 
Obstrutiva Crônica; /fisiopatologia; Tolerância ao Exercício.
DoI: 10.590/1809-2950/238210114
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INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is 
a disease that affects primarily the lungs, but it also 
has significant systemic consequences that lead to 
the intolerance to physical exercises and activities 
of daily life. This systemic compromise has been re-
lated to survival and general status of patients with 
the disease1,2.
Dyspnea generated by changes in lung paren-
chyma leads patients to chronic sedentary life-
style. This cycle of dyspnea and sedentary lifestyle 
promotes peripheral muscular hypotrophy and 
reduced aerobic capacity, thus resulting in more 
intense ventilatory demand for dynamic activi-
ties and closing the cycle called dyspnea-sedentary 
lifestyle-dyspnea3,4.
Common characteristics in patients with COPD, 
such as low body mass index (BMI), history of smoking, 
age, inactivity, systemic inflammation and systemic cor-
ticorteroids are important risk factors for osteoporosis. 
The severity of COPD is related to the loss of vertebral 
bone mineral density5.
Killian et al.6 first described the importance of this 
musculoskeletal change in the physical ability of pa-
tients with COPD, once patients complained about 
muscle without necessarily complaining about dyspnea 
during physical activity.
Different studies5,7 relate the severity of COPD 
with low BMI and with bone density, among other 
factors, associated with the presence of vertebral frac-
tures. However, there are a few studies relating the 
functional capacity, by means of field tests, with body 
composition, especially with the use of reliable meth-
ods, such as electric bioimpedance. Studies that prove 
the correlation of these measures are important, once 
the evaluation of body composition requires special-
ized devices that are not accessible, while field tests are 
easy to perform and apply.
Based on that, the objective of this study was to 
verify if there is a relationship between the different 
items of body composition, such as functional ca-
pacity and the severity of the condition in patients 
with COPD.
METHODOLOGY
This cross-sectional study was approved by the Ethics 
Committee of UNINOVE (protocol n. 384767/2011), 
and the sample was comprised of 20 patients di-
agnosed with COPD in outpatient follow-up, 
coming from the pneumology outpatient clinic of 
Santa Casa de Misericórdia de São Paulo (AME) “Dr. 
Geraldo Bourrol”. 
Patients from both genders were included, aged 
more than 40 years old and diagnosed with COPD 
according to criteria from the Global Initiative for 
Chronic Obstructive Lung Disease (GOLD). They 
should be clinically stable, without presenting picture of 
disease exacerbation in the past 30 days, and they could 
not be part of any program involving physical activity 
concomitantly. 
Patients with severe comorbidities, such as pre-
vious heart disease, orthopedic conditions in upper 
and lower limbs, motor or visual sequelae from neu-
rological disease that might interfere with the abil-
ity to perform physical exercises, uncontrolled arte-
rial hypertension, associated pulmonary disease and 
those that did not agree to participate in this study 
were excluded. 
resumen  |  La enfermedad pulmonar obstructiva crónica 
(EPOC) está relacionada con un bajo índice de masa corporal 
(IMC),  reducción de la capacidad funcional y reducción de la 
densidad ósea, justificando así la importancia de evaluar todos 
estos parámetros en pacientes con la enfermedad. Este es un 
estudio transversal, con una muestra de 20 pacientes, que se 
sometieron a la medición de la composición corporal por bioim-
pedancia, la evaluación de la capacidad funcional por la distan-
cia recorrida en el Incremental Shuttle Walk Test (ISWT) y la eva-
luación de la gravedad de la obstrucción por la espirometría. Se 
encontraron diferencias significativas entre la distancia recorri-
da y prevista del ISWT (p<0,01), correlaciones positivas entre la 
masa muscular y la distancia en el ISWT (r=0,54 con p=0,01), con 
FEV
1
 (r=0,488 con p=0,02 ), FEV
1
 y la masa ósea (r=0,497 
con p=0,02) y la distancia recorrida con el FEV
1
 (r=0,541 con 
p=0,01) . Las correlaciones encontradas en este estudio, además 
de confirmar la hipótesis de que la gravedad de la obstrucción 
presentada por los cambios en el parénquima pulmonar en pa-
cientes con EPOC se asocia con cambios en la composición 
corporal y la reducción de la capacidad funcional, evidencian 
también la correlación con la masa ósea.
Palabras clave  |  Índice de Masa Corporal; Enfermedad 
Obstructiva Crónica/fisiopatología; Tolerancia al Ejercicio.
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Procedures
Data about past and current history of the disease were 
collected, and a general physical examination was con-
ducted to ensure the impossibility of exacerbation. 
Afterwards, the assessment of the severity of obstruction, 
body composition and functional capacity was conducted 
according to the following flowchart (Figure 1). 
Spirometry
All of the patients were submitted to spirometric evalu-
ation to classify the severity of obstruction, and the fol-
lowing pulmonary volumes, capacities and flows were 
registered: Slow Vital Capacity (VC), Forced Vital 
Capacity (FVC) and its derivations, such as Forced 
Expiratory Volume in one second (FEV1) and the ra-
tios (FEV1/FVC and FEV1/VC). The test consisted of 
maximal inspiratory and expiratory maneuvers, which 
were conducted in the device, until it was possible to 
register three reproducible maneuvers according to the 
recommendations8. All of the tests were conducted in 
a climatized environment, by means of previously cali-
brated PFT KoKo® spirometer. The used reference val-
ues were in accordance with Pereira et al.9.
Incremental Shuttle Walk Test
The Incremental Shuttle Walk Test (ISWT), which 
aims at assessing the functional capacity of the pa-
tient, was conducted by a trained evaluator in a 10 
meter long corridor with two cones placed 0.5 meter 
from the end of the route (in order to minimize abrupt 
direction changes) and with the support of a beeping 
sound device, that guided the test. The beginning of 
the test was indicated by a triple beep. Afterwards, 
this device emitted a single beep in regular intervals, 
which warned when the subject should leave one ex-
tremity of the route to the other, before a new beep 
was emitted. Each new cycle initiated by a beep pre-
sented incremented speed standardized by Singh10. 
The explanation for the patients was standardized 
and demonstrated before each test. Each patient 
was advised to walk at a constant pace, aiming to go 
around the cone and continuing to walk until feel-
ing unable to maintain the necessary speed to reach 
the other extremity of the route before the next beep, 
without being extremely out of breath. During the 
whole test, data concerning heart rate (HR), periph-
eral oxygen saturation (SpO2), blood pressure (BP), 
respiratory frequency (RF), sensation of dyspnea and 
lower limb fatigue by the Borg scale were monitored. 
These data were written down every new stage of the 
test. Oxygen supplementation could be performed in 
case the patient presented with desaturation below 
80%. The test was performed twice, according to the 
recommendations by Singh10, with the objective of 
eliminating possible learning effects. Between each 
performed test, a 15-minute break was given to the 
patient in order for him or her to recover, so that his 
or her vital signs could return to basal levels10.
Body composition
The body composition of patients was assessed by 
means of an electrical bioimpedance balance, from 
Tanita™ BIA (foot to foot). Patients were instruct-
ed to respect the following instructions: not to eat or 
drink 4 hours before the test; not to ingest caffeine 
or alcohol 12 hours prior to the test; not to perform 
physical activities 6 hours before the test; and urinate 
30 minutes before the test. 
The measuring electrode was located on the feet 
platform, and reading was performed by the direct 
contact with the skin, which had been previously 
cleaned with 70% alcohol. The patient was advised to Figure 1. Experimental procedure
Population (n=20)
General physical examination
Spirometry
Evaluation of body composition
Evaluation of functional capacity  
(1st ISWT)
Evaluation of functional capacity  
(2nd ISWT)
REST
ISWT: Incremental Shuttle Walk Test
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stand on the scale on orthostatic position for the time 
established by the device. Body composition calcula-
tions were provided automatically by the scale itself, 
based on the data inserted by the evaluator about 
height, sex and age of each patient. Comparison data 
to what was expected for the sex were provided by the 
manufacturer11. 
Statistical analysis
After submission to the Kolmogorov Smirnov (KS) 
test, non-parametric data of the predicted value and 
the obtained one were analyzed by the non-paired 
t-test and the Wilcoxon test. For the correlation of 
parametric data, the Pearson correlation was used, 
and for non-parametric variables, the Spearman cor-
relation was used. Relevant results were those pre-
senting 5% significance level (p≤0.05). The software 
Minitab 14 was used. 
The sample power was calculated in 90%. By as-
suming a 0.05 alpha error, based on a study that de-
termines the clinically significant difference for the 
Incremental Shuttle Walking Test in 78.7 meters, 
and the standard-deviation being calculated by a 
98.59 meter pilot-study, the considered sample num-
ber was not lower than 16.
RESULTS
Results were organized in tables, for each variable, by 
mean and standard-deviation, or interquartile inter-
val according to the nature of the analyzed data. 
It is Worth to mention that in the previous evalu-
ation conducted with the patients, no case of clinical 
picture exacerbation was detected, because they were 
all stable to be included in the proposed protocol. 
Anthropometric and spirometric data of the studied 
sample are presented in Table 1.
During the ISWT, initial and final measures 
were registered referring to the percentage of HR, 
SpO2, as well as the report of dyspnea and lower 
extremity fatigue, by the Borg scale, and also BP. 
According to the results of Table 2, none of these 
variables presented any clinical or statistically sig-
nificant changes.
The non-paired t-test was applied for the predict-
ed and the coursed distance in ISWT, and a signifi-
cant difference with p<0.01 was found. 
The results of the test and the results of body com-
position, obtained by bioimpedance, are also found 
in Table 2, in mean and standard-deviation of the 
following variables: fat percentage, water percentage, 
muscle mass weight and bone mass weight. 
The distance coursed in ISWT presented moderate 
correlation with muscle mass (as presented in Figure 2).
The distance coursed in ISWT also presented sim-
ilar positive correlation with FEV1 (r=0.54; p=0.01),
FEV1 also presented correlation with thin and 
bone mass, as illustrated in Figures 3 and 4.
DISCUSSION
According to literature, patients with COPD have 
reduced physical abilities1-4, which have been as-
sessed by means of the coursed distance in ISWT, in 
comparison to predicted values for each individual 
Table 1. Mean and standard-deviation of the anthropometric (age, weight, 
height and body mass index) and spirometric variables (in liters and 
percentage of the predicted value)
Anthropometric variables
n=20 (7♀)
Mean±SD
Age (years) 65.9±5.4
Weight (kg) 63.69±17.9
Height (m) 1.62±0.1
BMI (kg/m2) 24.1±5.8
Spirometric variables  
n=20 (7♀)
Mean±SD
FVC (L) 3.08±0.8
FVC (% predicted) 86.5±22.1
FEV
1 
(L) 1.53±0.69
FEV
1 
(% predicted) 57.1±20.9
FEV
1
/FVC (L) 0.53±0.1
FEV
1
/FVC (% predicted) 67.0±16.5
BMI: Body mass index; FVC: Forced Vital Capacity; FEV
1
: Forced Expiratory Volume in one  
second; FEV
1
/FVC: Ratio FEV
1
/FVC, % predicted: percentage of the predicted value; ♀: women;  
SD: standard deviation
Table 2. Means and standard-deviation of the Incremental Shuttle Walk 
Test and body composition
ISWT Variables
n=20 (7♀)
Mean±SD
Maximum HR 106±16
% maximum HR 68±10
CD (meters) 205.1±96.7
% predicted CD 62.6±21.5
Body composition
n=20 (7♀)
Mean±SD
% fat 24.0±10.3
% water 52.3±7.7
Muscle mass weight (kg) 44.7±9.1
Bone mass weight (kg) 2.4±0.45
ISWT: Incremental Shuttle Walk Test; HR: heart rate; %: percentage; CD: coursed distance; 
♀: women; SD: standard deviation
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Bone mass versus FEV
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Figura 4. Correlation between forced expiratory volume in one second 
and bone mass
Muscle mass versus distance in ISWT
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Figure 2. Correlation between coursed distance in the Incremental Shuttle 
Walk Test and muscle mass weight
Muscle mass versus FEV
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Figure 3. Correlation between muscle mass and forced expiratory volume 
in one second
according to age, weight, height and gender12. This is 
in accordance with our findings, which also revealed 
significant difference between the coursed distance 
by the patients with COPD and the predicted dis-
tance in ISWT. These physical ability results have 
been considered to be essentially important to ex-
press the functional capacity of patients with COPD, 
according to literature7,13,14.
With regard to body composition, even though 
Pelegrino et al.15 stated that the reduced muscle mass 
is correlated to worse physical performance in relation 
to the presented fatigue, not being directly related to 
the reduced coursed distance in field tests, findings 
from other studies in literature showed up to 60% 
variation in the 12-minute walk test16, and positive 
significant correlation between muscle mass and the 
result of the 6-minute walk test17. With these find-
ings, with our results we could confirm the correlation 
between muscle mass and the distance coursed also 
in ISWT, besides the correlation between pulmonary 
function and bone mass, which was not explored in 
that context in literature.
The correlation we found between FEV1 and the 
coursed distance in ISWT is in accordance with 
the deconditioning concept, which is related to this 
population, since the lack of muscle use, especially 
peripheral muscles, due to the intense dyspnea pre-
sented by these patients during physical activities, 
leads them to present with muscle atrophy. The more 
severe the patient (lower FEV1), the lower the func-
tional capacity due to the lower muscle recruitment 
during activities of daily life. This finding is in ac-
cordance with the review by Nasis et al.7, who also 
explained the lack of use of peripheral muscles as the 
cause of reduced muscle mass. 
Besides this direct relationship between muscle mass 
and physical performance, which is well documented, 
especially among athletes, it is important to consider 
the possible correlations between the decreased pulmo-
nary function and bone mass changes, especially in this 
population of patients with COPD, who are also elders. 
The level of pulmonary obstruction, demonstrated by 
the decreased FEV1, is also associated with the risk of 
osteoporosis, since Kjensli18 has detected that the num-
ber of vertebral deformities is twice as high among 
women with COPD, GOLD III, in comparison to 
those who presented with GOLD II. By using the bio-
impedance we could observe that the bone mass weight 
was correlated with the severity of the disease, observed 
by the decreased FEV1.
Even though the bone mass evaluation did not earn 
much attention from patients with COPD, these results 
are important especially because all of the patients in 
the sample had been on corticoids for at least ten years. 
The most severe cases used higher doses, for longer pe-
riods of time, and the predisposition to osteoporosis 
ISWT: Incremental Shuttle Walk Test FEV
1 
: forced expiratory volume in one second
FEV
1 
: forced expiratory volume in one second
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and fractures are related to the use of corticosteroids, as 
explored by Vestergaard19.
It is important to consider some limitations in 
this study, especially the absence of a Control Group. 
However, the found results not only confirmed previous 
findings in literature, but they also called the attention to 
other aspects besides pulmonary function, as its relation-
ship with the compromised physical performance, partic-
ularly with body composition. Therefore, they can subsi-
dize treatment programs, especially of Cardiorespiratory 
and Musculoskeletal Physical Therapy, therefore, the 
lower the ability for exercise presented in field tests, the 
higher the severity of the disease and the higher the risk 
of fractures and bone deformities. Therefore, the pre-
scription of physical exercise should approach not only 
deconditioning, but protective and guidance activities. In 
some situations, a multiprofessional approach, such as the 
nutritional program for gaining thin mass, is also valid. 
CONCLUSION
The correlations found in this study confirm the hy-
pothesis that the severity of the obstruction presented 
by changes in the lung parenchyma in patients with 
COPD is related to changes in body composition and 
to the reduced functional capacity. Particularly, it is im-
portant to consider the importance of assessing other 
aspects besides the pulmonary function of patients with 
COPD, especially the correlation of pulmonary func-
tion and bone mass.
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